Clinical Trials Directory

Trials / Completed

CompletedNCT04133896

Circulating IL-6, Clusterin and Irisin in Obese Subjects

Circulating IL-6, Clusterin and Irisin in Obese Subjects With Different Grades of Obesity: Association With Insulin Resistance and Sexual Dimorphism

Status
Completed
Phase
Study type
Observational
Enrollment
176 (actual)
Sponsor
Rehab Werida · Academic / Other
Sex
All
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

evaluate the circulating levels of IL-6, clusterin and irisin in obese subjects of both sexes who had different classes of obesity and their sexual dimorphism also identify the association of IL-6, clusterin and irisin with insulin resistance.

Detailed description

Aim: Firstly, this study aimed at assessing the circulating levels of IL-6, clusterin and irisin in obese subjects of both sexes who had different classes of obesity and evaluating their sexual dimorphism and secondly evaluate the association of IL-6, clusterin and irisin with insulin resistance. Method: This study was conducted on 176 non-diabetic subjects of both sexes. Participants were classified according to their sex into two groups; the male and female groups. The male group (88 men) was classified according to BMI into; group 1 (22 lean men), group 2 (22 class I obese men), group 3 (22 class II obese men), and group 4 (22 class III obese men). The female group (88 women) was also classified according to BMI exactly as the male group. Fasting blood glucose, fasting insulin, lipid panel, serum IL-6, clusterin and irisin levels were measured. One-way analysis of variance followed by Tukey's as post hoc test was used for comparison of variables.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIL-6, Clusterin, Irisin LevelBlood samples to determine levels of Circulating IL-6, Clusterin and Irisin

Timeline

Start date
2018-02-01
Primary completion
2019-06-01
Completion
2019-06-30
First posted
2019-10-21
Last updated
2019-10-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04133896. Inclusion in this directory is not an endorsement.